SPMC J Health Care Serv. 2020;6(1):4 ARK: https://n2t.net/ark:/76951/jhcs94gn2f
1Department of Surgery, Southern Philippines Medical Center, JP Laurel Ave, Davao City, Philippines
Correspondence Kliendio Rovillos, kliendio96@gmail.com
Received 20 February 2019
Accepted 29 June 2020
Cite as Rovillos K, Arancel F. Healthcare-associated infections among patients in a surgery ward: cross-sectional study. SPMC J Health Care Serv. 2019;6(1):4. https://n2t.net/ark:/76951/jhcs94gn2f
Table 1 Sociodemographic and clinical characteristics of all patients | |||||||
Characteristics | n | Total | n | With HAI | n | Without HAI | p-value |
---|---|---|---|---|---|---|---|
Mean age ± SD, years | 182 | 34.89 ± 20.56 | 17 | 40.88 ± 23.48 | 165 | 34.27 ± 20.22 | 0.2075 |
Sex, frequency (%) | 182 | 17 | 165 | 0.4495 | |||
Male | 122 (67.03) | 10 (58.82) | 112 (67.88) | ||||
Female | 60 (32.97) | 7 (41.18) | 53 (32.12) | ||||
Smoker, frequency (%) | 81 | 17 (20.99) | 9 | 2 (22.22) | 72 | 15 (20.83) | 1.0000* |
Alcoholic beverage drinker, frequency (%) | 73 | 11 (15.07) | 9 | 0 (0.00) | 64 | 11 (17.19) | 0.3383* |
Comorbidities, frequency (%)† | 94 | 10 | 84 | ||||
Asthma | 1 (1.06) | 0 (0.00) | 1 (1.19) | 1.0000* | |||
Anemia | 2 (2.13) | (0.00) | 2 (2.38) | 1.0000* | |||
Diabetes mellitus | 6 (6.38) | 1 (10.00) | 5 (5.95) | 0.5008* | |||
Chronic obstructive pulmonary disease | 1 (1.06) | (0.00) | 1 (1.19) | 1.0000* | |||
Hypertension | 17 (18.09) | 3 (30.00) | 14 (16.67) | 0.3802* | |||
Hydrocephalus | 1 (1.06) | (0.00) | 1 (1.19) | 1.0000* | |||
History of stroke | 1 (1.06) | (0.00) | 1 (1.19) | 1.0000* | |||
Hypothyroidism | 1 (1.06) | (0.00) | 1 (1.19) | 1.0000* | |||
Hyperthyroidism | 2 (2.13) | (0.00) | 2 (2.38) | 1.0000* | |||
Pulmonary tuberculosis | 2 (2.13) | 1 (10.00) | 1 (1.19) | 0.2025* | |||
Multiple injuries | 4 (4.26) | 0 (0.00) | 4 (4.76) | 1.0000* | |||
* Fisher’s exact test † One patient may have more than one HAI=healthcare-associated infections |
Table 2 Preoperative clinical profiles of all patients | |||||||
Characteristics | Total (n=182) |
With HAI (n=17) |
Without HAI (n=165) |
p-value | |||
---|---|---|---|---|---|---|---|
Diagnosis classification, frequency (%) | |||||||
Trauma | 46 (25.41) | 4 (23.53) | 42 (25.61) | 1.0000* | |||
Vascular problems | 4 (2.20) | 0 (0.00) | 4 (2.42) | 1.0000* | |||
Soft tissue/extremities disorders | 7 (3.85) | 0 (0.00) | 7 (4.24) | 1.0000* | |||
Abdomen | 90 (49.45) | 9 (52.94) | 81 (49.09) | 0.7624 | |||
Urology | 12 (6.59) | 1 (5.88) | 11 (6.67) | 1.0000* | |||
Thoracic problems | 2 (1.10) | 0 (0.00) | 2 (1.21) | 1.0000* | |||
Breast disorders | 7 (3.85) | 2 (11.76) | 5 (3.03) | 0.1306* | |||
Head and neck disorders | 8 (4.40) | 1 (5.88) | 7 (4.24) | 0.5510* | |||
Congenital anomalies | 6 (3.30) | 0 (0.00) | 6 (3.64) | 1.0000* | |||
Had any surgical procedure, frequency (%) | 126 (69.23) | 12 (70.59) | 114 (69.09) | 0.8987 | |||
Use of any indwelling medical devices, frequency (%)† | 86 (47.25) | 12 (70.59) | 74 (44.85) | 0.0429‡ | |||
Endotracheal tube | 76 (41.76) | 12 (70.59) | 64 (38.79) | ||||
Urinary catheter | 84 (46.15) | 12 (70.59) | 72 (43.64) | ||||
Central venous pressure catheter | 4 (2.20) | 2 (11.76) | 2 (1.21) | ||||
Chest tube | 9 (4.95) | 2 (11.76) | 7 (4.24) | ||||
Internal jugular catheter | 4 (2.20) | 0 (0.00) | 4 (2.42) | ||||
Abdominal drain | 3 (1.65) | 1 (0.61) | 2 (11.76) | ||||
Tracheostomy tube | 1 (0.55) | 0 (0.00) | 1 (0.61) | ||||
Blood transfusion, frequency (%) | 33 (18.13) | 2 (11.76) | 31 (18.79) | 0.7417* | |||
Mean length of hospital stay ± SD, days | 9.76 ± 8.87 | 18.24 ± 9.48 | 8.88 ±8.36 | <0.0001‡ | |||
* Fisher’s exact test † One patient may have more than one indwelling medical device ‡ Significant at p<0.05 |
Table 3 Intraoperative and postoperative clinical profiles of patients who underwent surgery | |||||||
Characteristics | Total (n=126) |
With HAI (n=12) |
Without HAI (n=114) |
p-value | |||
---|---|---|---|---|---|---|---|
Mean duration of surgery ± SD, minutes | 100.94 ± 94.11 | 209.75 ± 101.69 | 89.48 ± 86.03 | <0.0001* | |||
Mean number of personnel ± SD | 4.26 ± 1.40 | 5.00 ± 1.13 | 4.18 ± 1.41 | 0.0552 | |||
Urgency of surgery, frequency (%) | 0.8356 | ||||||
Emergency | 77 (61.11) | 7 (58.33) | 70 (61.40) | ||||
Elective | 49 (38.89) | 5 (41.67) | 44 (38.60) | ||||
Type of surgery, frequency (%) | |||||||
Minimally invasive surgery | 24 (19.05) | 2 (16.67) | 22 (19.30) | 0.8252 | |||
Open surgical procedure | 79 (62.70) | 9 (75.00) | 70 (61.40) | 0.5326† | |||
Appendectomy | 32 (40.51) | 1 (11.11) | 31 (44.29) | ||||
Gastrointestinal | 16 (20.25) | 2 (22.22) | 14 (20.00) | ||||
Gynecologic | 1 (1.27) | 0 (0.00) | 1 (1.43) | ||||
Head and neck | 5 (6.33) | 1 (11.11) | 4 (5.71) | ||||
Inguinal hernia | 4 (5.06) | 1 (11.11) | 3 (4.29) | ||||
Neurosurgery | 1 (1.27) | 0 (0.00) | 1 (1.43) | ||||
Trauma | 11 (13.92) | 3 (33.33) | 8 (11.43) | ||||
Urologic | 6 (7.59) | 1 (11.11) | 5 (7.14) | ||||
Vascular | 1 (1.27) | 0 (0.00) | 1 (1.43) | ||||
Gastrointestinal and thoracic | 1 (1.27) | 0 (0.00) | 1 (1.43) | ||||
Gastrointestinal and urologic | 1 (1.27) | 0 (0.00) | 1 (1.43) | ||||
Breast surgery | 4 (3.17) | 1 (8.33) | 3 (2.63) | 0.3333† | |||
Minor surgical procedures | 17 (13.49) | 0 (0.00) | 17 (14.91) | 0.3672† | |||
Orthopedic surgery | 2 (1.59) | 0 (0.00) | 2 (1.75) | 1.0000† | |||
Surgical wound classification, frequency (%) ‡ | |||||||
I | 17 (13.49) | 1 (8.33) | 16 (14.04) | 1.0000† | |||
II | 55 (43.65) | 5 (41.67) | 50 (43.86) | 0.8842 | |||
III | 29 (23.02) | 2 (16.67) | 27 (23.68) | 0.7318† | |||
IV | 25 (19.84) | 4 (33.33) | 21 (18.42) | 0.2532† | |||
Anesthetic technique, frequency (%)§ | |||||||
General anesthesia║ | 71 (56.35) | 11 (91.67) | 60 (52.63) | 0.0121*† | |||
Regional or local anesthesia | 68 (53.97) | 2 (16.67) | 66 (57.89) | 0.0119*† | |||
Anesthetic agent, frequency (%)§ | |||||||
Bupivacaine | 50 (39.68) | 2 (16.67) | 48 (42.11) | 0.1224† | |||
Lidocaine | 12 (9.52) | 0 (0.00) | 12 (10.53) | 0.6034† | |||
Inhalational anesthetic agents¶ | 67 (53.17) | 10 (83.33) | 57 (50.00) | 0.0342*† | |||
Propofol | 2 (1.59) | 0 (0.00) | 2 (1.75) | 1.0000† | |||
Unspecified general (inhalation) anesthetic agent | 2 (1.59) | 1 (0.88) | 1 (8.33) | 0.1821† | |||
Unspecified regional anesthetic agent | 5 (4.39) | 0 (0.00) | 5 (4.39) | 1.0000† | |||
Reoperation, frequency (%)** | 6 (3.53) | 2 (16.67) | 4 (3.51) | 0.1008† | |||
* Significant at p<0.05 † Fisher’s exact test ‡ Surgical Wound Class (SWC): I - clean, SWC II - clean/contaminated, SWC III - contaminated, SWC IV - dirty § One patient may have had more than one anesthetic technique or anesthetic agent ║ Administered by inhalation and/or intravenous route ¶ Isoflurane or sevoflurane ** Patients with at least two operations done during the same admission |
Table 4 Logistic regression analysis showing the association of hospital acquired infection and selected clinical characteristics among all patients | |||||||
Characteristics | Unadjusted | Adjusted for age and sex | |||||
---|---|---|---|---|---|---|---|
Prevalence odds ratio (95% CI) | p-value | Prevalence odds ratio (95% CI) | p-value | ||||
Smoker | 1.09 (0.20 to 5.78) | 0.9217 | 0.59 (0.10 to 3.66) | 0.5734 | |||
Comorbidities | |||||||
Diabetes mellitus | 1.76 (0.19 to 16.76) | 0.6217 | 1.19 (0.11 to 12.57) | 0.8834 | |||
Hypertension | 2.14 (0.49 to 9.31) | 0.3093 | 1.46 (0.29 to 7.31) | 0.6405 | |||
Pulmonary tuberculosis | 9.22 (0.53 to 160.41) | 0.1273 | 5.85 (0.30 to 114.59) | 0.2448 | |||
Diagnosis | |||||||
Trauma | 0.89 (0.28 to 2.89) | 0.8513 | 1.21 (0.34 to 4.31) | 0.7694 | |||
Abdomen | 1.17 (0.43 to 3.17) | 0.7626 | 1.11 (0.40 to 3.06) | 0.8400 | |||
Urology | 0.88 (0.11 to 7.22) | 0.9013 | 0.79 (0.09 to 6.92) | 0.8339 | |||
Breast disorders | 4.27 (0.76 to 23.91) | 0.0987 | 3.57 (0.54 to 23.51) | 0.1857 | |||
Head and neck disorders | 1.41 (0.16 to 12.20) | 0.7540 | 1.13 (0.13 to 10.05) | 0.9140 | |||
Length of stay >7 days | 27.28 (3.53 to 210.79) | 0.0015* | 26.25 (3.39 to 203.40) | 0.0018* | |||
Use of any indwelling medical devices | 2.95 (0.99 to 8.76) | 0.0.0511 | 3.03 (1.01 to 9.07) | 0.0475* | |||
Blood transfusion | 0.58 (0.13 to 2.65) | 0.4809 | 0.50 (0.11 to 2.35) | 0.3803 | |||
Any surgical procedure | 1.07 (0.36 to 3.20) | 0.8998 | 1.08 (0.36 to 3.25) | 0.8912 | |||
* Significant at p<0.05 |
Table 5 Logistic regression analysis showing the association of hospital acquired infection and selected surgical characteristics among patients who underwent surgery | |||||||
Characteristics | Unadjusted | Adjusted for age and sex | |||||
---|---|---|---|---|---|---|---|
Prevalence odds ratio (95% CI) | p-value | Prevalence odds ratio (95% CI) | p-value | ||||
Emergency operation | 0.88 (0.26 to 2.95) | 0.8357 | 1.09 (0.30 to 3.99) | 0.8989 | |||
Surgical procedure of >180 minutes | 15.54 (4.10 to 58.87) | 0.0001* | 15.18 (3.92 to 58.69) | 0.0001* | |||
More than 4 surgery team members | 5.55 (1.42 to 21.65) | 0.0137* | 5.42 (1.37 to 21.41) | 0.0158* | |||
General anesthesia† | 9.90 (1.24 to 79.17) | 0.0307* | 10.46 (1.29 to 84.63) | 0.0278* | |||
Use of any inhalational anesthetic agents‡ | 10.62 (1.33 to 84.91) | 0.0260* | 11.81 (1.45 to 96.08) | 0.0210* | |||
Minimally invasive surgery | 0.84 (0.17 to 4.09) | 0.8255 | 0.63 (0.12 to 3.33) | 0.5872 | |||
Open surgery | 1.88 (0.48 to 7.33) | 0.3618 | 2.40 (0.58 to 9.88) | 0.2253 | |||
Breast surgery | 3.37 (0.32 to 35.16) | 0.3105 | 2.98 (0.26 to 33.74) | 0.3774 | |||
Reoperation§ | 5.50 (0.89 to 33.84) | 0.0658 | 5.18 (0.82 to 32.87) | 0.0809 | |||
Surgical wound class III or IV║ | 1.38 (0.42 to 4.52) | 0.6002 | 1.57 (0.46 to 5.41) | 0.4706 | |||
*Significant at p<0.05
† Administered by inhalation and/or intravenous route ‡ Isoflurane or sevoflurane § Patients with at least two operations done during the same admission ║Surgical wound class (SWC) III - contaminated, SWC IV - dirty |
Table 6 Characteristics of hospital-acquired infections in 17 patients from the surgery ward | |||||||
Characteristics | Values n=17 |
||||||
---|---|---|---|---|---|---|---|
Hospital acquired infection, frequency (%)* | |||||||
Hospital-acquired pneumonia | 9 (52.94) | ||||||
Ventilator-associated pneumonia | 4 (23.53) | ||||||
Surgical site infection | 3 (17.65) | ||||||
Urinary tract infection | 1 (5.88) | ||||||
Phlebitis | 2 (11.76) | ||||||
Antibiotic administered, frequency (%)† | |||||||
Ceftriaxone | 6 (35.29) | ||||||
Ciprofloxacin | 3 (17.65) | ||||||
Coamoxiclav | 1 (5.88) | ||||||
Cefuroxime | 4 (23.53) | ||||||
Metronidazole | 4 (23.53) | ||||||
Sultamicillin | 1 (5.88) | ||||||
Cefoxitin | 6 (35.29) | ||||||
Amoxicillin | 1 (5.88) | ||||||
Clarithromycin | 2 (11.76) | ||||||
Ertapenem | 1 (5.88) | ||||||
Meropenem | 1 (5.88) | ||||||
Cefepime | 1 (5.88) | ||||||
* One patient may have more than one hospital acquired infection
† One patient may have more than one antibiotic administered |
Ethics approval
This study was reviewed and approved by the Department of Health XI Cluster Ethics Review Committee (DOH XI CERC reference P15042801).
Reporting guideline used
Article source
Submitted
Peer review
External
Funding
Supported by personal funds of the authors
Competing interests
None declared
Access and license
This is an Open Access article licensed under the Creative Commons Attribution-NonCommercial 4.0 International License, which allows others to share and adapt the work, provided that derivative works bear appropriate citation to this original work and are not used for commercial purposes. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0/.
1. World Health Organization. The burden of health care-associated infection worldwide [Internet]. Geneva: World Health Organization; c2020 [cited 2020 June 29]. Available from: https://www.who.int/infection-prevention/publications/burden_hcai/en/.
2. Revelas A. Healthcare - associated infections: A public health problem. Niger Med J. 2012 Apr;53(2):59-64.
3. Vegas AA, Jodra VM, García ML. Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization. Eur J Epidemiol. 1993 Sep;9(5):504-10.
4. Veen EJ, Janssen-Heijnen ML, de Jongh MA, Roukema JA. Incidence and type of complications in non-operated patients at a surgical ward. Patient Saf Surg. 2010 Jul 20;4(1):11.
5. Toufen C, Franca SA, Okamoto VN, Salge JM. Infection as an independent risk factor for mortality in the surgical intensive care unit. Clinics (Sao Paulo). 2013;68(8):1103-8.
6. Bainbridge - Bainbridge D, Martin J, Arango M, Cheng D. Evidence-based Peri-operative Clinical Outcomes Research (EPiCOR) Group. Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis. Lancet 2012; 380:1075–1081.
7. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009; 360:491–499.
8. Cui P, Fang X. Pathogenesis of infection in surgical patients. Curr Opin Crit Care. 2015 Aug;21(4):343-50.
9. Fakhry - Fakhry SM, Montgomery SC. Peri-operative oxygen and the risk of surgical infection. Surg Infect (Larchmt) 2012; 13:228–233.
10. Leaper - Leaper DJ. Risk factors for and epidemiology of surgical site infections. Surg Infect (Larchmt) 2010; 11:283–287.
11. Navoa-Ng JA, Rosenthal VD, Asetre-Luna I, Yu C. Healthcare-associated infection rates, extra length of stay and mortality in a hospital of the Philippines. Findings of the INICC. Am. J. Infect. Control. 2007;35:E55–E56.
12. Mitchell KF, Barker AK, Abad CL, Safdar N. Infection control at an urban hospital in Manila, Philippines: a systems engineering assessment of barriers and facilitators. Antimicrob Resist Infect Control. 2017 Sep 2;6:90.
13. Ramirez JD. Surgical Site Infection (SSI) Prevention Project. Manuscript of SPMC, Center of Health Development, DOH, Quality Improvement and Patient Safety Section [unpublished]. Davao: Southern Philippines Medical Center; 2015.
14. Shah F, Gandhi M, Mehta V, Udani D, Mundra M, Swadia N. Nosocomial infections in surgical wards. The Internet Journal of Surgery. 2009;24(1).
15. Mulu, W, G. Kibru, G. Beyene, and M. Damtie. 2012. Prospective Nosocomial Infection and Antimicrobial Resistance Pattern of Bacteria Isolates among Patients Admitted at Felege Hiwot Referral Hospital, Bahirdar Ethhiopia. Ethiop J Health Sci. 2012. Marc/ 22(1):7-18
16. Amin ZA, Nahar N. Hospital acquired infection in a tertiary military hospital in Dhaka, Bangladesh. International Journal of Infectious Diseases and Therapy. 2017;2(2): 35-39.
17. Wallace WC, Cinat M, Gornick WB, Lekawa ME, Wilson SE. Nosocomial infections in the surgical intensive care unit: a difference between trauma and surgical patients. Am Surg. 1999 Oct;65(10):987-90.
18. Ahmed M, Alam NS, Manzar SO. Post-operative wound infection: a surgeon's dilemma. Pakistan J Surg. 2007;23:41–47.
19. Lilani PS, Janagale N, Chowdhar A, et al. Surgical site infection in clean & clean-contaminated cases. Indian J Micro Biol. 2005;23:249–252.
20. Togo A, Traore A, Kante L, et al. Fighting nosocomial infection rates in the general surgery department of the teaching hospital Gabriel Toure in Bamako, Mali. The Op Biol J. 2010;3:87–91.
21. Tolera M, Marami D, Abate D, Dheresa M. Are Invasive Procedures and a Longer Hospital Stay Increasing the Risk of Healthcare-Associated Infections among the Admitted Patients at Hiwot Fana Specialized University Hospital, Eastern Ethiopia? Adv Prev Med. 2020 Mar 31;2020:6875463.
22. Weldu MG, Berhane H, Berhe N, Haile K, Sibhatu Y, Gidey T, et al. Magnitude and Determinant Factors of Surgical Site Infection in Suhul Hospital Tigrai, Northern Ethiopia: A Cross-Sectional Study. Surg Infect (Larchmt). 2018 Oct;19(7):684-690.
23. Bereket W, Hemalatha K, Getenet B, Wondwossen T, Solomon A, Zeynudin A, Kannan S. Update on bacterial nosocomial infections. Eur Rev Med Pharmacol Sci. 2012 Aug;16(8):1039-44.
24. Bellissimo F, Pinzone MR, Tedesco MC, Cacopardo B. Mortality rate and length of stay due to hospital acquired infections in a metropolitan hospital in Sicily. Infectious Diseases and Tropical Medicine. 2015;1(3):e142.
25. Zhou C, Chen H, Deng M. Study on direct economic loss induced by nosocomial infections in hospitalized patients of a three A hospital and control strategies. Se Pu. 2014 24(21):5396-98.
26. Barrasa-Villar JI, Aibar-Remón C, Prieto-Andrés P, Mareca-Doñate R, Moliner-Lahoz J. Impact on Morbidity, Mortality, and Length of Stay of Hospital-Acquired Infections by Resistant Microorganisms. Clin Infect Dis. 2017 Aug 15;65(4):644-652.
27. Ali S, Birhane M, Bekele S, Kibru G, Teshager L, Yilma Y, Ahmed Y, Fentahun N, Assefa H, Gashaw M, Gudina EK. Healthcare associated infection and its risk factors among patients admitted to a tertiary hospital in Ethiopia: longitudinal study. Antimicrob Resist Infect Control. 2018 Jan 5;7:2.
28. Rahmqvist M, Samuelsson A, Bastami S, Rutberg H. Direct health care costs and length of hospital stay related to health care-acquired infections in adult patients based on point prevalence measurements. Am J Infect Control. 2016 May 1;44(5):500-6.
29. Jia H, Li L, Li W, Hou T, Ma H, Yang Y, Wu A, Liu Y, Wen J, Yang H, Luo X, Xing Y, Zhang W, Wu Y, Ding L, Liu W, Lin L, Li Y, Chen M. Impact of healthcare-associated infections on length of stay: A study in 68 Hospitals in China. BioMed Research International, 2019.
30. Evaristo-Méndez G, Rocha-Calderón CH. Factores de riesgo para neumonía nosocomial en pacientes con cirugía abdominal [Risk factors for nosocomial pneumonia in patients with abdominal surgery]. Cir Cir. 2016 Jan-Feb;84(1):21-7.
31. Hajjar J, Girard R. Surveillance des infections nosocomiales liées à l'anesthésie. Etude multicentrique [Surveillance of nosocomial infections related to anesthesia. A multicenter study]. Ann Fr Anesth Reanim. 2000 Jan;19(1):47-53.
32. Yuki K. The impact of anaesthetics on immune function. 2017 Jun 19 [cited 2020 Jun 29]. In: Research Features [Internet]. England: Research Publishing International Ltd. c2017. Available from: https://researchfeatures.com/2017/06/19/impact-anaesthetics-immune-function/?cn-reloaded=1.
33. Loftus RW, Koff MD, Burchman CC, Schwartzman JD, Thorum V, Read ME, Wood TA, Beach ML. Transmission of pathogenic bacterial organisms in the anesthesia work area. Anesthesiology. 2008 Sep;109(3):399-407.
34. Reichman DE, Greenberg JA. Reducing surgical site infections: a review. Rev Obstet Gynecol. 2009 Fall;2(4):212-21.
35. Gailienė G, Gierasimovič Z, Petruševičienė D, Macijauskienė A. The prevalence of health care-associated infections and risk factors in a university hospital. Medicina (Kaunas). 2012;48(8):399-403.
36. Sattar F, Sattar Z, Zaman M, Akbar S. Frequency of Post-operative Surgical Site Infections in a Tertiary Care Hospital in Abbottabad, Pakistan. Cureus. 2019 Mar 12;11(3):e4243.
37. Pathak A, Mahadik K, Swami MB, Roy PK, Sharma M, Mahadik VK, Lundborg CS. Incidence and risk factors for surgical site infections in obstetric and gynecological surgeries from a teaching hospital in rural India. Antimicrob Resist Infect Control. 2017 Jun 14;6:66.
38. Mahdi H, Goodrich S, Lockhart D, DeBernardo R, Moslemi-Kebria M. Predictors of surgical site infection in women undergoing hysterectomy for benign gynecologic disease: a multicenter analysis using the national surgical quality improvement program data. J Minim Invasive Gynecol. 2014 Sep-Oct;21(5):901-9.
39. Bu N, Zhao E, Gao Y, Zhao S, Bo W, Kong Z, Wang Q, Gao W. Association between perioperative hypothermia and surgical site infection: A meta-analysis. Medicine (Baltimore). 2019 Feb;98(6):e14392.
40. Damani NN. Manual of Infection Control Procedures. London: Greenwich Medical Media Limited; 2003.
41. Maryam K, Zahra K, Reza ATM, Mehdi MS. Relationship between blood transfusion and risk of nosocomial infeciton in intensive care unit patients. Iran J Clin Infect Dis. 2012;7(1):21-24.
42. Sherertz RJ, Bassetti S, Bassetti-Wyss B. "Cloud" health-care workers. Emerg Infect Dis. 2001;7(2):241-244.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms: